NAMD submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the development of the Medicare and multi-payer provider incentive program created under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The letter, which responds to CMS’ request for information, offers insight on the inclusion of Medicaid alternative payment models in the program […]

Continue reading

NAMD submitted comments in response to CMS’ paper, “Medicaid Services ‘Received Through’ an Indian Health Service/Tribal Facility: A Request for Comment”. The paper seeks to revise interpretation of Section 1905 (b) of the Act to move towards parity in the federal matching rate for services furnished through Indian Health Services (IHS) or “638” tribally-operated health […]

Continue reading

Today, the National Association of Medicaid Directors released its Fourth Annual State Medicaid Operations Survey—offering a window into the nation’s Medicaid programs at the 50th anniversary of the program.  The survey results demonstrate the variety and the coherence among the 56 Medicaid programs, and exemplify the changing job of “Medicaid Director” in the 50 states, […]

Continue reading

NAMD Comments on 340B Omnibus Guidance

NAMD submitted comments to the Health Resources and Services Administration (HRSA)’s proposed omnibus guidance addressing several aspects of the 340B drug discount program. Read the full comments.

Continue reading

Today, NAMD urged Congressional committees of jurisdiction to take immediate action to avert the 52% increase in Medicare Part B premiums slated to take effect on January 1, 2016. The letter notes that the financial burden of this increase falls primarily on Medicaid programs, as the premium increase applies to only 30% of Part B […]

Continue reading

NAMD Comments on 340B Ceiling Price Rule

NAMD provided written comments to the Health Resources and Services Administration on its proposed rule addressing ceiling prices and manufacturer civil monetary penalties in the 340B drug discount program. Read the full letter here.

Continue reading

Today, the National Association of Medicaid Directors submitted comments to Vicki Wachino, Director, Center for Medicaid & CHIP Services, Centers for Medicare & Medicaid Services at the U.S. Department of Health and Human Services on the proposed rule, Medicaid and Children’s Health Insurance Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies and Revisions […]

Continue reading

This issue brief, developed by the National Association of Medicaid Directors (NAMD) in partnership with the Association of Maternal & Child Health Programs (AMCHP), lays out key background information and the elements of state strategies to address the excessive use of C-sections for low-risk, first time mothers. It is important to note that this resource […]

Continue reading

NAMD Gives Testimony on 1115 Waivers

Today, Matt Salo, executive director of the National Association of Medicaid Directors, gave testimony before the Energy and Commerce Committee, Subcommittee on Health on “Examining the Administration’s Approval of Medicaid Demonstration Projects.” Read the full testimony here.

Continue reading